Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Other Non Operating Income (2019 - 2025)

OptimizeRx (OPRX) has disclosed Other Non Operating Income for 7 consecutive years, with $59000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 51.28% to $59000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $197000.0 through Dec 2025, up 29.61% year-over-year, with the annual reading at $198000.0 for FY2025, 30.26% up from the prior year.
  • Other Non Operating Income hit $59000.0 in Q4 2025 for OptimizeRx, down from $62000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $720419.0 in Q2 2023 to a low of -$1.6 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged $90435.6 across 5 years, with a median of $39000.0 in 2024.
  • Biggest YoY gain for Other Non Operating Income was 22182300.0% in 2023; the steepest drop was 392.3% in 2023.
  • Year by year, Other Non Operating Income stood at $2382.0 in 2021, then skyrocketed by 22507.56% to $538512.0 in 2022, then crashed by 392.3% to -$1.6 million in 2023, then surged by 102.48% to $39000.0 in 2024, then skyrocketed by 51.28% to $59000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for OPRX at $59000.0 in Q4 2025, $62000.0 in Q3 2025, and $37000.0 in Q2 2025.